Osaka, Japan

Norihiko Seko

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kanebo, Limited. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Norihiko Seko. Retrieved from https://idiyas.com/inventor/norihiko-seko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Norihiko Seko: Innovator in Pharmaceutical Chemistry

Introduction

Norihiko Seko is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that serve important medical purposes. His work has led to advancements in the treatment of conditions related to platelet aggregation.

Latest Patents

Norihiko Seko holds a patent for "Novel 4,5-Bis (4-methoxyphenyl)-2-(pyrrol-2-yl) thiazoles." This patent includes a detailed description of compounds that can be utilized as platelet aggregation inhibitors. The patent outlines a process for the preparation of these compounds, which are crucial for developing effective pharmaceutical compositions.

Career Highlights

Seko is associated with Kanebo, Limited, where he has been instrumental in research and development. His innovative approach has led to the creation of compounds that have the potential to improve patient outcomes in various medical scenarios.

Collaborations

Throughout his career, Norihiko Seko has collaborated with notable colleagues, including Koichiro Yoshino and Koichi Yokota. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Norihiko Seko's contributions to pharmaceutical chemistry exemplify the impact of innovation in medicine. His patented work on platelet aggregation inhibitors showcases his dedication to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…